This study aims to understand THC pharmacology and the safety of cannabis vaping, including the pharmacology and safety of co-administration of nicotine and THC. The study is designed as a within-subjects single-blinded crossover study. Fourteen smokers of tobacco cigarettes and cannabis will switch between three conditions, namely: (a) vaping cannabis leaf, (b) vaping tobacco containing nicotine and (c) vaping a combination of cannabis leaf and tobacco containing nicotine. All participants will vape each product with the PAX loose-leaf vaporizer. The study will be conducted during three outpatient visits separated by at least 48 hours. The order of treatment (cannabis leaf, tobacco with nicotine, cannabis leaf \& tobacco with nicotine) will be counterbalanced between subjects. Subjects will be blinded to the content of the vaporizer on the study day but will be told during screening that they will vape cannabis alone, tobacco alone, and cannabis plus tobacco with nicotine.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean Delivered and Retained Doses
Timeframe: Study Day 1-3
Median Peak THC Concentration (Cmax)
Timeframe: Study Day 1-3
Median Peak Nicotine Concentration (Cmax)
Timeframe: Study Day 1-3
Median THC Exposure
Timeframe: Study Day 1-3
Median Nicotine Exposure
Timeframe: Study Day 1-3
Mean Heart Rate
Timeframe: Study Day 1-3
Mean Score on the Drug Effects Questionnaire (DEQ)
Timeframe: Study Day 1-3
Mean Scores on the Marijuana Craving Questionnaire-Short Form (MCQ-SF)
Timeframe: Study Day 1-3
Mean Scores on the Modified Cigarette Evaluation Questionnaire (mCEQ)
Timeframe: Study Day 1-3
Mean Scores on the Positive Affect Negative Affect Schedule (PANAS)
Timeframe: Study Day 1-3
Mean Scores on the Minnesota Nicotine Withdrawal Scale (MNWS)
Timeframe: Study Day 1-3